Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 24, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

[Early-onset colorectal carcinoma study].

Janick Selves1, Sylviane Olschwang

  • 1J. Selves : Inserm U563, CPTP, CHU Purpan, BP 3028, 31024 Toulouse Cedex 3, France.janick.selves@toulouse.inserm.fr

Medecine Sciences : M/S
|April 14, 2009
PubMed
Summary

Early-onset colorectal carcinoma (CRC) shows distinct molecular features. Transcriptome analysis reveals differing gene expression profiles, paving the way for a specific molecular signature for early-onset CRC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do not underestimate cryptosporidium: case report of a rare cause of acute liver failure in transplant recipients.

BMC infectious diseases·2026
Same author

From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Molecular endoscopy with next-generation sequencing improves diagnosis of cholangiocarcinoma in patients with extrahepatic biliary strictures.

JHEP reports : innovation in hepatology·2026
Same author

A deceptively benign biliary lesion revealing an ALK-rearranged intrahepatic cholangiocarcinoma.

Histopathology·2026
Same author

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Molecular oncology·2026
Same author

[Case #6. Adenocarcinoma with a dMMR phenotype].

Annales de pathologie·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Context:

  • Early-onset colorectal carcinoma (CRC) presents unique clinical and molecular characteristics.
  • A study investigated non-familial early-onset CRC within the CIT program.
  • Understanding these tumors is crucial due to their aggressive nature.

Purpose:

  • To characterize the molecular mechanisms driving early-onset colorectal carcinoma.
  • To identify potential molecular signatures specific to this patient group.
  • To compare genomic profiles with late-onset CRC.

Summary:

  • Transcriptome analysis of early-onset CRC revealed distinct gene-expression profiles.
  • Gene expression appears to vary with age within the early-onset group.
  • Genomic profiles were similar to those of late-onset colon cancers.

Impact:

  • Findings may lead to the development of a specific molecular signature for early-onset CRC.
  • This signature could aid in earlier diagnosis and targeted therapies.
  • Contributes to a deeper understanding of CRC carcinogenesis.

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Related Experiment Videos

Last Updated: Jun 24, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010